{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:15:03Z","timestamp":1790709303873,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Chronic kidney disease (CKD) is associated with increased mortality, with cardiovascular disease (CVD) being the primary cause of death. Proper lipid regulation may reduce CVD risk and slow CKD progression. While there is evidence that a higher plant protein intake could ameliorate lipid levels in the general population, the effects of this dietary regimen within the CKD population remain uncertain, with studies providing conflicting results. We aim to investigate the impact of increased plant protein intake on the lipid levels of CKD patients. Methods: Two electronic databases (PubMed, Scopus) were reviewed for controlled clinical trials assessing the effect of increased plant protein intake versus the usual CKD animal-based diet in CKD patients, published until June 2024. Results: Eleven trials, encompassing 248 patients, were included in this meta-analysis. Overall, compared to the usually recommended CKD diet, increased plant protein intake was associated with statistically significant reductions in total cholesterol (\u221224.51 mg\/dL, 95% CI \u221240.33, \u22128.69), low-density lipoprotein (LDL) (\u221221.71 mg\/dL, 95% CI \u221238.32, \u22125.1), triglycerides (\u2212 21.88 mg\/dL, 95% CI \u221235.34, \u22128.40), and Apolipoprotein B levels (\u221211.21 mg\/dL, 95% CI \u221218.18, \u22124.25). No significant changes were observed in high-density lipoprotein (HDL) (0.09 mg\/dL, 95% CI \u22121.82, 1.99) and Apolipoprotein A levels (0.04 mg\/dL, 95% CI \u22127.14, 7.21). Conclusions: Increased plant protein intake, mainly from soy, reduces total cholesterol, LDL, triglycerides, and ApoB in adult CKD patients. Further research is needed to assess these effects in dialysis patients and explore non-soy plant sources.<\/jats:p>","DOI":"10.3390\/nu17091408","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:43:37Z","timestamp":1745379817000},"page":"1408","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Increased Plant Protein Intake on the Lipid Profile of Chronic Kidney Disease Patients: A Meta-Analysis of Controlled Clinical Trials"],"prefix":"10.3390","volume":"17","author":[{"given":"Ioanna","family":"Papaodyssea","sequence":"first","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-358X","authenticated-orcid":false,"given":"Areti","family":"Lagiou","sequence":"additional","affiliation":[{"name":"Department of Public and Community Health, School of Public Health, University of West Attica, 122 43 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tzoulaki","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK"},{"name":"Systems Biology, Biomedical Research Institution Academy of Athens, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Valanou","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1610-1813","authenticated-orcid":false,"given":"Androniki","family":"Naska","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"ref_2","unstructured":"WHO (2010). Global health estimates: Leading causes of death. Cause-specific mortality, 2010. Global Health Observatory, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S2214-109X(24)00050-0","article-title":"The major global burden of chronic kidney disease","volume":"12","author":"Jadoul","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_5","unstructured":"(2020). Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 395, 709\u2013733."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","article-title":"Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?","volume":"15","author":"Vallianou","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: Current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3904\/kjim.2013.28.1.22","article-title":"Diastolic dysfunction and chronic kidney disease","volume":"28","author":"Cho","year":"2013","journal-title":"Korean J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/joim.12290","article-title":"Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease","volume":"277","author":"Calabresi","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000488816","article-title":"Disorders of Lipid Metabolism in Chronic Kidney Disease","volume":"46","author":"Bulbul","year":"2018","journal-title":"Blood Purif."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","article-title":"Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease","volume":"153","author":"Moradi","year":"2009","journal-title":"Transl. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1159\/000490686","article-title":"Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency","volume":"43","author":"Cackowska","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874192401105010041","article-title":"Dyslipidemia associated with chronic kidney disease","volume":"5","author":"Tsimihodimos","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ejcn.2014.112","article-title":"The effects of soy protein on chronic kidney disease: A meta-analysis of randomized controlled trials","volume":"68","author":"Zhang","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., and Welch, V.A. (2019). Cochrane Handbook for Systematic Reviews of Interventions, John Wiley & Sons. [2nd ed.].","DOI":"10.1002\/9781119536604"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.ajkd.2005.08.031","article-title":"Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients","volume":"46","author":"Chen","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1079\/BJN20051646","article-title":"Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis","volume":"95","author":"Chen","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.jrn.2013.01.017","article-title":"Soy milk consumption and blood pressure among type 2 diabetic patients with nephropathy","volume":"23","author":"Miraghajani","year":"2013","journal-title":"J. Ren. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000045021","article-title":"Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients","volume":"79","author":"Soroka","year":"1998","journal-title":"Nephron"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1347s","DOI":"10.1093\/ajcn\/68.6.1347S","article-title":"Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes","volume":"68","author":"Anderson","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.ejcn.1601688","article-title":"Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy","volume":"57","author":"Azadbakht","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jn\/134.8.1874","article-title":"Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy","volume":"134","author":"Teixeira","year":"2004","journal-title":"J. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0140-6736(92)90731-H","article-title":"Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome","volume":"339","author":"Gentile","year":"1992","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0101-28002011000200006","article-title":"Short-term effects of soy protein diet in patients with proteinuric glomerulopathies","volume":"33","author":"Ahmed","year":"2011","journal-title":"J. Bras. Nefrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/dc07-2065","article-title":"Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: A longitudinal randomized clinical trial","volume":"31","author":"Azadbakht","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3747\/pdi.2009.00161","article-title":"Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients: A randomized controlled trial","volume":"30","author":"Tabibi","year":"2010","journal-title":"Perit. Dial. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e006659","DOI":"10.1161\/JAHA.117.006659","article-title":"Effect of Plant Protein on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"6","author":"Li","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/07315724.2011.10719947","article-title":"Soy Protein Effects on Serum Lipoproteins: A Quality Assessment and Meta-Analysis of Randomized, Controlled Studies","volume":"30","author":"Anderson","year":"2011","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00592-020-01534-4","article-title":"Effects of plant protein and animal protein on lipid profile, body weight and body mass index on patients with hypercholesterolemia: A systematic review and meta-analysis","volume":"57","author":"Zhao","year":"2020","journal-title":"Acta Diabetol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bara\u0144ska, A., B\u0142aszczuk, A., Kanadys, W., Baczewska, B., J\u0119drych, M., Wawryk-Gawda, E., and Polz-Dacewicz, M. (2021). Effects of Soy Protein Containing of Isoflavones and Isoflavones Extract on Plasma Lipid Profile in Postmenopausal Women as a Potential Prevention Factor in Cardiovascular Diseases: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 13.","DOI":"10.3390\/nu13082531"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2008.04.006","article-title":"Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol","volume":"200","author":"Harland","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/ajcn\/85.4.1148","article-title":"Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials","volume":"85","author":"Taku","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1080\/10408398.2019.1689097","article-title":"The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis","volume":"60","author":"Moradi","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bara\u0144ska, A., B\u0142aszczuk, A., Polz-Dacewicz, M., Kanadys, W., Malm, M., Janiszewska, M., and J\u0119drych, M. (2021). Effects of Soy Isoflavones on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 13.","DOI":"10.3390\/nu13061886"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/gme.0b013e3181cb85d3","article-title":"One-year soy protein supplementation does not improve lipid profile in postmenopausal women","volume":"17","author":"Campbell","year":"2010","journal-title":"Menopause"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/ajcn\/85.4.960","article-title":"Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects","volume":"85","author":"Matthan","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ajcn\/83.2.244","article-title":"Effect of soy protein varying in isoflavone content on serum lipids in healthy young men","volume":"83","author":"McVeigh","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/clc.23027","article-title":"Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks","volume":"41","author":"Najjar","year":"2018","journal-title":"Clin. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3945\/jn.109.109595","article-title":"Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes","volume":"139","author":"Pipe","year":"2009","journal-title":"J. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1523-1755.2000.00814.x","article-title":"Studies of renal injury III: Lipid-induced nephropathy in type II diabetes","volume":"57","author":"Dominguez","year":"2000","journal-title":"Kidney Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1681\/ASN.V114669","article-title":"Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats","volume":"11","author":"Joles","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"F1297","DOI":"10.1152\/ajprenal.90761.2008","article-title":"Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney","volume":"296","author":"Kim","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_52","first-page":"1599","article-title":"Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome","volume":"26","author":"Lee","year":"2011","journal-title":"Histol. Histopathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-024-02050-y","article-title":"High remnant-cholesterol levels increase the risk for end-stage renal disease: A nationwide, population-based, cohort study","volume":"23","author":"Jung","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2023.02.019","article-title":"Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study","volume":"111","author":"Pontremoli","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ckj\/sfz186","article-title":"Apolipoprotein B is a risk factor for end-stage renal disease","volume":"14","author":"Kwon","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ndt\/gfg229","article-title":"Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis","volume":"18","author":"Fanti","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1046\/j.1523-1755.1999.00464.x","article-title":"Survival advantage in Asian American end-stage renal disease patients","volume":"55","author":"Wong","year":"1999","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/07853899709113696","article-title":"Phyto-oestrogens and Western diseases","volume":"29","author":"Adlercreutz","year":"1997","journal-title":"Ann. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clnu.2015.03.012","article-title":"Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis","volume":"35","author":"Jing","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/jmf.2006.9.368","article-title":"Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients","volume":"9","author":"Siefker","year":"2006","journal-title":"J. Med. Food"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","volume":"74","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int. Suppl."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s41100-018-0195-2","article-title":"Oxidative stress in chronic kidney disease","volume":"4","author":"Ling","year":"2018","journal-title":"Ren. Replace. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Panizo, S., Mart\u00ednez-Arias, L., Alonso-Montes, C., Cannata, P., Mart\u00edn-Carro, B., Fern\u00e1ndez-Mart\u00edn, J.L., Naves-D\u00edaz, M., Carrillo-L\u00f3pez, N., and Cannata-And\u00eda, J.B. (2021). Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010408"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hewitson, T.D., Holt, S.G., and Smith, E.R. (2017). Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype\u2014Role of Risk Factors and Epigenetics. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00520"},{"key":"ref_65","first-page":"483","article-title":"Soy protein and genistein improves renal antioxidant status in experimental nephrotic syndrome","volume":"34","author":"Javanbakht","year":"2014","journal-title":"Nefrologia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1600461","DOI":"10.1002\/mnfr.201600461","article-title":"Dietary low-fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation","volume":"61","author":"Jheng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1177\/0962280215583568","article-title":"Random-effects meta-analysis: The number of studies matters","volume":"26","author":"Guolo","year":"2017","journal-title":"Stat. Methods Med. Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"von Hippel, P.T. (2015). The heterogeneity statistic I2 can be biased in small meta-analyses. BMC Med. Res. Methodol., 15.","DOI":"10.1186\/s12874-015-0024-z"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcn.81.2.397","article-title":"Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile","volume":"81","author":"Zhan","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM199508033330502","article-title":"Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids","volume":"333","author":"Anderson","year":"1995","journal-title":"New Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1002\/fsn3.1809","article-title":"Comprehensive overview of the quality of plant- And animal-sourced proteins based on the digestible indispensable amino acid score","volume":"8","author":"Herreman","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"van den Berg, L.A., Mes, J.J., Mensink, M., and Wanders, A.J. (2022). Protein quality of soy and the effect of processing: A quantitative review. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1004754"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.121.057807","article-title":"Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab","volume":"146","author":"Steg","year":"2022","journal-title":"Circulation"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/9\/1408\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:41Z","timestamp":1760030381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/9\/1408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":74,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["nu17091408"],"URL":"https:\/\/doi.org\/10.3390\/nu17091408","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}